Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
Everolimus is an mTOR inhibitor studied in the research of various cancers, including renal cell carcinoma and certain types of breast cancer. | ||||||
Ridaforolimus | 572924-54-0 | sc-212783 | 5 mg | $248.00 | 1 | |
Ridaforolimus is an investigational mTOR inhibitor being studied for its potential in various types of cancer. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $173.00 $230.00 $275.00 $332.00 | 9 | |
BKM120 is a PI3K inhibitor that has been studied for its potential in breast cancer and other solid tumors. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $189.00 | 4 | |
CAL-101 is a PI3K-delta inhibitor that has been studied in hematologic malignancies. | ||||||
Saracatinib | 379231-04-6 | sc-364607 sc-364607A | 10 mg 200 mg | $113.00 $1035.00 | 7 | |
Saracatinib is a dual PI3K/mTOR inhibitor that has been evaluated for its anticancer effects. |